JBC INTERFERin siRNA transfection reagent

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M601552200 on August 1, 2006

J. Biol. Chem., Vol. 281, Issue 40, 29606-29613, October 6, 2006
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
281/40/29606    most recent
M601552200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by van den Born, J.
Right arrow Articles by Berden, J. H. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van den Born, J.
Right arrow Articles by Berden, J. H. M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

No Change in Glomerular Heparan Sulfate Structure in Early Human and Experimental Diabetic Nephropathy*

Jacob van den Born{ddagger}1, Brenda Pisa{ddagger}, Marinka A. H. Bakker{ddagger}, Johanna W. A. M. Celie§, Carin Straatman{ddagger}, Steven Thomas, Gian C. Viberti, Lena Kjellen||, and Jo H. M. Berden{ddagger}

From the {ddagger}Department of Nephrology, Radboud University Medical Center Nijmegen, P. O. Box 9101, 6500 HB Nijmegen, The Netherlands, the §Department of Molecular Cell Biology and Immunology, VU University Medical Center, P. O. Box 7057, 1007 MB Amsterdam, The Netherlands, the Department of Diabetes, Endocrinology, and Internal Medicine, Guy's Hospital, St. Thomas Street, London SE1 9RT, United Kingdom, and the ||Department of Medical Biochemistry and Microbiology, Uppsala University, Box 582, SE-751 23, Uppsala, Sweden

Heparan sulfate (HS) proteoglycans are major anionic glycoconjugates of the glomerular basement membrane and are thought to contribute to the permeability properties of the glomerular capillary wall. In this study we evaluated whether the development of (micro) albuminuria in early human and experimental diabetic nephropathy is related to changes in glomerular HS expression or structure. Using a panel of recently characterized antibodies, glomerular HS expression was studied in kidney biopsies of type I diabetic patients with microalbuminuria or early albuminuria and in rat renal tissue after 5 months diabetes duration. Glomerular staining, however, revealed no differences between control and diabetic specimens. A significant (p < 0.05) ~60% increase was found in HS N-deacetylase activity, a key enzyme in HS sulfation reactions, in diabetic glomeruli. Structural analysis of glomerular HS after in vivo and in vitro radiolabeling techniques revealed no changes in HS N-sulfation or charge density. Also HS chain length, protein binding properties, as well as disaccharide composition did not differ between control and diabetic glomerular HS samples. These results indicate that in experimental and early human diabetic nephropathy, increased urinary albumin excretion is not caused by loss of glomerular HS expression or sulfation and suggest other mechanisms to be responsible for increased glomerular albumin permeability.


Received for publication, February 17, 2006 , and in revised form, July 13, 2006.

* This work was supported by a grant from the Dutch Diabetes Foundation (DFN 940-10-009). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 To whom correspondence should be addressed: Dept. of Molecular Cell Biology and Immunology VU University Medical Center, P. O. Box 7057, 1007 MB Amsterdam, The Netherlands. Tel.: 31-20-444-8078; Fax: 31-20-444-8081; E-mail: j.vandenborn{at}vumc.nl.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
C. Ruster, T. Bondeva, S. Franke, M. Forster, and G. Wolf
Advanced glycation end-products induce cell cycle arrest and hypertrophy in podocytes
Nephrol. Dial. Transplant., July 1, 2008; 23(7): 2179 - 2191.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
C. Rippe, A. Rippe, O. Torffvit, and B. Rippe
Size and charge selectivity of the glomerular filter in early experimental diabetes in rats
Am J Physiol Renal Physiol, November 1, 2007; 293(5): F1533 - F1538.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
S. J. Harvey, G. Jarad, J. Cunningham, A. L. Rops, J. van der Vlag, J. H. Berden, M. J. Moeller, L. B. Holzman, R. W. Burgess, and J. H. Miner
Disruption of Glomerular Basement Membrane Charge through Podocyte-Specific Mutation of Agrin Does Not Alter Glomerular Permselectivity
Am. J. Pathol., July 1, 2007; 171(1): 139 - 152.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
S. J. Harvey and J. H. Miner
Breaking Down the Barrier: Evidence against a Role for Heparan Sulfate in Glomerular Permselectivity
J. Am. Soc. Nephrol., March 1, 2007; 18(3): 672 - 674.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2006 by the American Society for Biochemistry and Molecular Biology.